New Aptar Mumbai Site Boosts Manufacturing Power in Southeast Asia

The expansion is expected to create significant benefits:

• Increased manufacturing capacity: Meeting the rising demand for Aptar Pharma's products in Southeast Asia.

• Enhanced service and support: Providing customers with faster and more agile solutions.

• Creation of new jobs: Fueling the growth of local talent and the pharmaceutical industry in India.

Sanjay Kapote, President, India & Head, Pharma – SEA, highlighted the advantages of the new site: "This new facility in Mumbai offers a larger space, not only for assembly operations but also for further localization and bringing in additional Aptar Pharma technologies tailored for the Asian market."

Aptar Pharma's commitment to India was further emphasized by Alex Theodorakis, President, Aptar Pharma Prescription: "India is a key pillar in the pharma ecosystem, and this new chapter marks continued growth in the region."

Xiangwei Gong, President, Aptar Asia, congratulated the team on the successful completion of the project: "This new site will enhance our local capabilities, allowing us to be closer to our customers and serve them with greater speed and agility. It also presents exciting growth opportunities for local talent and the business itself."

With its state-of-the-art infrastructure and strategic location, the new Aptar Mumbai site is poised to play a vital role in strengthening Aptar Pharma's presence in Southeast Asia and contributing to the advancement of the region's pharmaceutical industry.